New study tests if teaching breast Self-Exams saves lives
NCT ID NCT07348744
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a structured education program to help women learn and practice breast self-exams. 76 women aged 20-69 will be randomly assigned to receive the program or not. Researchers will measure changes in self-exam behavior, breast cancer knowledge, awareness, and fear levels.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Health Belief Model-Based Education Program
- What this could lead to
- If successful, this program could increase breast self-examination rates and awareness, potentially aiding early detection.
- What could go wrong
- This is a small, early-stage behavioral study with no direct medical intervention. Results may not generalize beyond this specific population.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 76 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jan 2026
An estimate. Start dates often move.
- Expected to finish
-
Aug 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
20 to 69 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Being affiliated with Family Health Center No. 1 in Ardahan Province, * Being a woman between the ages of 20 and 69, * Being literate, * Not having been diagnosed with breast cancer, * Not having a mental or communication disorder, * Having a phone available for communication, * Women who voluntarily agree to participate in the study. Exclusion Criteria: * Difficulty communicating, * Wanting to drop out of the study, * Not wanting to participate in the study. * Women who did not fill out the data form despite reminders via message and phone call.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Kafkas University
Kars, Kars, 36100, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a common steroid shield breast cancer patients from a dangerous drug side effect?
- Tiny magnetic seeds could guide surgeons to the right lymph node
- New PET tracer aims to light up hidden cancer targets
- Gut bacteria supplement tested against chemo hair loss
- Can a mindfulness program boost Self-Compassion in breast cancer survivors?
- Can a Decades-Old Anti-Inflammatory drug quiet the joint pain that drives women off breast cancer therapy?